TSHR and type 2 diabetes mellitus: Notably, altered β-arrestin expression—particularly reduced β-arrestin-2 levels—has been implicated in aging-related conditions such as neurodegeneration and type 2 diabetes (53), suggesting that diminished β-arrestin-2 in older individuals may enhance the efficiency of TSHR-mediated inflammatory signaling.